Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| DACA-d6 | N-[2-(Dimethylamino)ethyl]-4-acridinecarboxamide-d6; DACA-d6; N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide-d6; NSC 601316-d6 | NA | C18H13D6N3O | 299.4 | N-[2-(Dimethylamino)ethyl]-4-acridinecarboxamide-d6; DACA-d6; N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide-d6; NSC 601316-d6
|
| Dacarbazine | 5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide; DTIC; DIC; NSC-45388; Dacatic; Deticene; | 4/3/4342 | C6H10N6O | 182.18 | 5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide; DTIC; DIC; NSC-45388; Dacatic; Deticene;
|
| Dacarbazine-d6 | 5-[3,3-Di-(methyl-d3)-1-triazenyl]imidazole-4-carboxamide; DTIC-d6; DIC-d6; NSC-45388-d6; Dacatic-d6; Deticene-d6; | 1185241-28-4 | C6H4D6N6O | 188.22 | 5-[3,3-Di-(methyl-d3)-1-triazenyl]imidazole-4-carboxamide; DTIC-d6; DIC-d6; NSC-45388-d6; Dacatic-d6; Deticene-d6;
|
| Lopinavir | (alphaS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide; A 157378.0; ABT 378; Aluviran; Koletra; | 192725-17-0 | C37H48N4O5 | 628.8 | (alphaS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H... |
| Daclatasvir | N,N’-[[1,1’-biphenyl]-4,4’-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-carbamic Acid C,C’-Dimethyl Ester; BMS 790052; EBP 883; | 1009119-64-5 | C40H50N8O6 | 738.88 | N,N’-[[1,1’-biphenyl]-4,4’-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-carbamic Aci... |
| Daclatasvir-d6 | N,N’-[[1,1’-biphenyl]-4,4’-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-carbamic Acid C,C’-Dimethyl Ester-d6; BMS 790052-d6; EBP 883-d6; | NA | C40H44D6N8O6 | 744.91 | N,N’-[[1,1’-biphenyl]-4,4’-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-carbamic Aci... |
| Daclatasvir Dihydrochloride | BMS 790052-05; N,N’-[[1,1’-Biphenyl]-4,4’-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C’-Dimethyl Ester Hydrochloride (1:2) | 1009119-65-6 | C40H52Cl2N8O6 | 811.8 | BMS 790052-05; N,N’-[[1,1’-Biphenyl]-4,4’-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]b... |
| Lopinavir-d8 | (alphaS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide-d8; A 157378.0-d8; ABT 378-d8; Aluviran-d8; Koletra-d8; | 1322625-54-6 | C37H40D8N4O5 | 636.85 | (alphaS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H... |
| Daclatasvir RSSR Isomer | N,N’-[[1,1’-Biphenyl]-4,4’-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1R)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C’-Dimethyl Ester | 1009107-27-0 | C40H50N8O6 | 738.88 | N,N’-[[1,1’-Biphenyl]-4,4’-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1R)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid... |
| Lopinavir Metabolite M-1 | (alphaS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2,4-dioxo-1(2H)-pyrimidineacetami-de; 4-Oxo Lopinavir | 192725-39-6 | C37H46N4O6 | 642.78 | (alphaS)-N-[(1S,3S,4S)-4-[[(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2,4-dioxo-1(... |
Page 1631 of 10017